MedTrace Logo

Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost

NCT01430923 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-07-12

No results posted yet for this study

Summary

The purpose of this study is to:

* To evaluate the efficacy of Refrigeration-Free Latanoprost compared to Latanoprost stored at refrigeration temperature with respect to the diurnal intraocular pressure (IOP) change from baseline after 3 months of therapy in patients with open-angle glaucoma (OAG) or ocular hypertension.
* To evaluate the safety and tolerability of Refrigeration-Free Latanoprost in patients with open-angle glaucoma (OAG) or ocular hypertension.

Conditions

Interventions

DRUG

refrigeration free latanoprost

latanoprost Eye drops 0.005% once daily, 3 months

DRUG

latanoprost eye drops

latanoprost eye drops 0.005% w/v, once daily, 3 months

Sponsors & Collaborators

  • Aurolab

    lead OTHER

Principal Investigators

  • Dr. Manju R Pillai, MBBS., · Araving Eye Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-05-31
Completion
2012-08-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01430923 on ClinicalTrials.gov